Pharming (PHAR) Stock Price, Quote, News & History | Benzinga

SPY764.10+0.02%QQQ703.11−0.19%BTC/USD81,727.63+0.52%DIA528.58+0.13%GLD368.74−0.07%TLT81.82+0.10%

Pharming Group (PHAR) Stock Price, Quote, News & History

PHARNASDAQ

Trade with Public

Trade with Public

$10.67

1.0210.57%

Last update: Oct 22, 9:29 AM

$10.57

0.929.53%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Compare Stock Report

Key Statistics

Open

$10.57

Close

$10.67

Volume / Avg.

21.60K / 22.73K

Day Range

$10.55 - $10.80

52 Wk Range

9.11 - 21.34

Market Cap

$748.12M

P/E Ratio

75.99

Dividend Yield

-

Exchange

NASDAQ

RSI

58

Short Interest

0.03%

Days to Cover

1

Recent Pharming Group N.V. News

Crude Oil Moves Higher; Lockheed Martin Posts Upbeat Earnings

U.S. stocks fell, led by a 2% Nasdaq drop; Lockheed Martin beat estimates and raised guidance. Oil rose, while global markets and metals declined.

Avi Kapoor

Healthcare Services Posts Upbeat Q3 Earnings, Joins Pool, Spotify And Other Big Stocks Moving Higher On Thursday

U.S. stocks fell, but Healthcare Services Group jumped 8.2% on an earnings beat. Biohaven led gainers, surging 30.5% after FDA news.

Avi Kapoor

Meta Posts Mixed Q2 Results, Joins Coursera, Qualcomm And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session

U.S. stock futures rise, Meta shares drop 9.4%, Teladoc Health and Rentokil Initial fall after mixed financial results.

Avi Kapoor

Snap, Whirlpool, Nerdwallet And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

U.S. stock futures up, Dow futures gain 0.1% as Snap (NYSE: SNAP) shares fall 10.5%, Fastly (NASDAQ: FSLY) down 21.6%, and other stocks decline in pre-market trading.

Avi Kapoor

Why Kulicke And Soffa Industries Shares Are Trading Higher By 19%; Here Are 20 Stocks Moving Premarket

Shares of Kulicke & Soffa Industries (NASDAQ: VECO) rose after beating earnings estimates. Other gainers include Global Engine, Agilon Health, and Blue Bird Corp.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

35.03M

Investing Cash Flow (TTM)

-85.24M

Financing Cash Flow (TTM)

-697.00K

Free Cash Flow (TTM)

34.37M

Capital Expenditure (TTM)

-660.00K

Net Change in Cash (TTM)

-50.91M

Analyst Trends and Forecast

1

Aug

2

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$705.14M

PE Ratio (TTM)

75.99

PE Ratio (FWD)

196.08

PEG Ratio (TTM)

-

PS Ratio (TTM)

2.05

PB Ratio (TTM)

2.77

Earnings Yield % (TTM)

1.32%

Earnings Yield % (FWD)

0.51%

EV / EBITDA (TTM)

18.12

Price / EBITDA (TTM)

19.28

Price / Free Cash Flow (TTM)

21.83

Book Value / Share

$3.82

Company Debt

Total Debt

$97.87M

LT Debt

$92.40M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$16.36M

Total Cash

$158.28M

Debt to Equity

0.42

Issuance of Debt (TTM)

-$16.36M

Repayment of Debt (TTM)

-$16.36M